UBE2Q1-AS1: UBE2Q1-AS1 is a long non-coding RNA (lncRNA) that has been implicated in various types of cancer, including ovarian cancer [PMC8521014]. It is part of an autophagy-related lncRNA signature that was established using the LASSO regression method [PMC8521014]. UBE2Q1-AS1 has also been identified as a member of prognostic models for gastric cancer, breast cancer, and bladder cancer [PMC9732092] [PMC9715909]. In bladder cancer, UBE2Q1-AS1 was found to be down-regulated in tumor tissues compared to normal tissues [PMC9715909]. Additionally, UBE2Q1-AS1 has been associated with gastric cancer development and was found to be lowly expressed in gastric cancer tissues [PMC9569729]. It is also part of a prognostic signature for bladder urothelial carcinoma (BLCA) and cuproptosis-related lncRNA signature for BLCA [PMC9289196] [PMC9701814]. Furthermore, UBE2Q1-AS1 has been identified as a risk factor for prediction in kidney renal clear cell carcinoma (KIRC) [PMC9550517]. It is located on chromosome 1 and is antisense to the UBE2Q1 gene. In addition to its association with various types of cancers, UBE2Q1-AS1 has also been found to be part of a larger loop that includes multiple genes involved in various biological processes [PMC6302745].